CompletedPhase 1NCT04131595

Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

Studying Encephalitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bavarian Nordic
Principal Investigator
Carlos Fierro, MD
JCCT
Intervention
MVA-BN-WEV Dose 1(biological)
Enrollment
45 enrolled
Eligibility
18-50 years · All sexes
Timeline
20192020

Study locations (1)

Collaborators

JPM CBRN Medical

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04131595 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis

← Back to all trials